PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Ouni, M.* ; Eichelmann, F.* ; Jähnert, M.* ; Krause, C.* ; Saussenthaler, S.* ; Ott, C.* ; Gottmann, P.* ; Speckmann, T.* ; Huypens, P. ; Wolter, S.* ; Mann, O.* ; Hrabě de Angelis, M. ; Beckers, J. ; Kirchner, H.* ; Schulze, M.B.* ; Schürmann, A.*

Differences in DNA methylation of HAMP in blood cells predicts the development of type 2 diabetes.

Mol. Metab. 75:101774 (2023)
Verlagsversion DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
OBJECTIVES: Better disease management can be achieved with earlier detection through robust, sensitive, and easily accessible biomarkers. The aim of the current study was to identify novel epigenetic biomarkers determining the risk of type 2 diabetes (T2D). METHODS: Livers of 10-week-old female New Zealand Obese (NZO) mice, slightly differing in their degree of hyperglycemia and liver fat content and thereby in their diabetes susceptibility were used for expression and methylation profiling. We screened for differences in hepatic expression and DNA methylation in diabetes-prone and -resistant mice, and verified a candidate (HAMP) in human livers and blood cells. Hamp expression was manipulated in primary hepatocytes and insulin-stimulated pAKT was detected. Luciferase reporter assays were conducted in a murine liver cell line to test the impact of DNA methylation on promoter activity. RESULTS: In livers of NZO mice, the overlap of methylome and transcriptome analyses revealed a potential transcriptional dysregulation of 12 hepatokines. The strongest effect with a 52% decreased expression in livers of diabetes-prone mice was detected for the Hamp gene, mediated by elevated DNA methylation of two CpG sites located in the promoter. Hamp encodes the iron-regulatory hormone hepcidin, which had a lower abundance in the livers of mice prone to developing diabetes. Suppression of Hamp reduces the levels of pAKT in insulin-treated hepatocytes. In liver biopsies of obese insulin-resistant women, HAMP expression was significantly downregulated along with increased DNA methylation of a homologous CpG site. In blood cells of incident T2D cases from the prospective EPIC-Potsdam cohort, higher DNA methylation of two CpG sites was related to increased risk of incident diabetes. CONCLUSIONS: We identified epigenetic changes in the HAMP gene which may be used as an early marker preceding T2D.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
8.100
0.000
3
1
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Epic-potsdam ; Epigenetic Markers ; Hepcidin ; T2d Risk ; Translational Approach; Hepcidin Levels; Epigenetic Memory; Iron Homeostasis; Liver; Risk; Mellitus; Insulin; Association; Biomarkers; Profiles
Sprache englisch
Veröffentlichungsjahr 2023
HGF-Berichtsjahr 2023
ISSN (print) / ISBN 2212-8778
e-ISSN 2212-8778
Zeitschrift Molecular Metabolism
Quellenangaben Band: 75, Heft: , Seiten: , Artikelnummer: 101774 Supplement: ,
Verlag Elsevier
Verlagsort Amsterdam
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Experimental Genetics (IEG)
POF Topic(s) 30201 - Metabolic Health
Forschungsfeld(er) Genetics and Epidemiology
PSP-Element(e) G-500600-004
G-500600-001
Förderungen DFG
European Community
German Cancer Aid
European Union
Federal Ministry of Science, Germany
Brandenburg State
German Research Foundation (DFG)
German Ministry of Education and Research
FUNDING from DFG
DOI 10.1016/j.molmet.2023.101774
WOS ID 001041655500001
Scopus ID 85166005455
PubMed ID 37429525
Erfassungsdatum 2023-10-06
[➜Korrektur melden]